SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 4

Intravascular ultrasound versus angiography-guided drug-eluting stent implantation in patients with complex coronary lesions: An updated meta-analysis of nine randomized clinical trials

Zhong Guo FAN
Meng Nan XU
Yuan Yuan XIAO
Hua Ling WANG
Bing XU
Sheng Hu HE
Pages
160–167
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compared to angiography guidance, IVUS-guided DES implantation was associated with significantly lower incidence of MACE [odds ratios (OR) 0.57, 95% confidence intervals (CI): 0.45–0.72, p<0.001; I2 =0.0%, p=0.674], cardiac death (OR 0.42, 95% CI: 0.21–0.82, p=0.010; I2 =0.0%, p=0.961), MI (OR 0.65, 95% CI: 0.44–0.95, p=0.027; I2 =41.8%, p=0.089), TVR (OR 0.55, 95% CI: 0.38–0.79, p=0.001; I2 =0.0%, p=0.916), target lesion revascularization (TLR) (OR 0.58, 95% CI: 0.41–0.82, p=0.002; I2 =0.0%, p=0.888), and ST (OR 0.48, 95% CI: 0.24–0.93, p=0.029; I2 =0.0%, p=0.733).Conclusion: The updated meta-analysis demonstrates that DES implantation under IVUS guidance leads to a significant reduction in MACE, cardiac death, MI, TVR, TLR, and ST among patients with complex coronary lesions. (Anatol J Cardiol 2019; 22: 160-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Intravascular ultrasound (IVUS) is not routinely performed in the real-world practice, and the benefits of IVUS-guided drug-eluting stent (DES) implantation in patients with complex coronary lesions remains unclear.
📊
Key Findings & Data:The risk of definite/probable stent thrombosis (ST) was chosen as the safety endpoint.Results: Nine randomized trials including a total of 3,612 patients with complex coronary lesions were finally analyzed.
💡
Conclusion & Impact:Compared to angiography guidance, IVUS-guided DES implantation was associated with significantly lower incidence of MACE [odds ratios (OR) 0.57, 95% confidence intervals (CI): 0.45–0.72, p<0.001; I2 =0.0%, p=0.674], cardiac death (OR 0.42, 95% CI: 0.21–0.82, p=0.010; I2 =0.0%, p=0.961), MI (OR 0.65, 95% CI: 0.44–0.95, p=0.027; I2 =41.8%, p=0.089), TVR (OR 0.55, 95% CI: 0.38–0.79, p=0.001; I2 =0.0%, p=0.916), target lesion revascularization (TLR) (OR 0.58, 95% CI: 0.41–0.82, p=0.002; I2 =0.0%, p=0.888), and ST (OR 0.48, 95% CI: 0.24–0.93, p=0.029; I2 =0.0%, p=0.733).Conclusion: The updated meta-analysis demonstrates that DES implantation under IVUS guidance leads to a significant reduction in MACE, cardiac death, MI, TVR, TLR, and ST among patients with complex coronary lesions. (Anatol J Cardiol 2019; 22: 160-7)
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Intravascular ultrasound (IVUS) is not routinely performed in the real-world practice, and the benefits of IVUS-guided drug-eluting stent (DES) implantation in patients with complex coronary lesions remains unclear. This updated meta-analysis attempts to evaluate the clinical outcomes of the IVUS guidance in these patients.Methods: We searched potential eligible citations from the PubMed, EMBASE, Medline, and other internet sources. The primary endpoint were major adverse cardiovascular events (MACE), including cardiac death, myocardial infarction (MI), and target vessel revascularization (TVR). The risk of definite/probable stent thrombosis (ST) was chosen as the safety endpoint.Results: Nine randomized trials including a total of 3,612 patients with complex coronary lesions were finally analyzed. Compared to angiography guidance, IVUS-guided DES implantation was associated with significantly lower incidence of MACE [odds ratios (OR) 0.57, 95% confidence intervals (CI): 0.45–0.72, p<0.001; I2 =0.0%, p=0.674], cardiac death (OR 0.42, 95% CI: 0.21–0.82, p=0.010; I2 =0.0%, p=0.961), MI (OR 0.65, 95% CI: 0.44–0.95, p=0.027; I2 =41.8%, p=0.089), TVR (OR 0.55, 95% CI: 0.38–0.79, p=0.001; I2 =0.0%, p=0.916), target lesion revascularization (TLR) (OR 0.58, 95% CI: 0.41–0.82, p=0.002; I2 =0.0%, p=0.888), and ST (OR 0.48, 95% CI: 0.24–0.93, p=0.029; I2 =0.0%, p=0.733).Conclusion: The updated meta-analysis demonstrates that DES implantation under IVUS guidance leads to a significant reduction in MACE, cardiac death, MI, TVR, TLR, and ST among patients with complex coronary lesions. (Anatol J Cardiol 2019; 22: 160-7)

🔖

Cite This Article

FAN, Z. G., XU, M. N., XIAO, Y. Y., WANG, H. L., XU, B., HE, S. H. (2019). Intravascular ultrasound versus angiography-guided drug-eluting stent implantation in patients with complex coronary lesions: An updated meta-analysis of nine randomized clinical trials. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 4, 160–167. https://ajindex.com/articles/367279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31
  2. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008
  3. Mintz GS. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 2007; 100: 26M-35M
  4. Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008; 29: 1851-7
  5. Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents. Circ Cardiovasc Interv 2016; 9: e003700
  6. Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, et al. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial. J Am Coll Cardiol 2018; 72: 3126-37
  7. Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation 2014; 129: 463-70
  8. Claessen BE, Mehran R, Mintz GS, Weisz G, Leon MB, Dogan O, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv 2011; 4: 974-81
  9. Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, et al. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JAMA 2015; 314: 2155-63
  10. Kim BK, Shin DH, Hong MK, Park HS, Rha SW, Mintz GS, et al. Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study. Circ Cardiovasc Interv 2015; 8: e002592
  11. Fan ZG, Gao XF, Li XB, Shao MX, Gao YL, Chen SL, et al. The outcomes of intravascular ultrasound-guided drug-eluting stent implantation among patients with complex coronary lesions: a comprehensive meta-analysis of